JUJHAR SINGH: Open Payments
NPI 1821527375 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 45 payments from 13 companies in 2025. Trend: 2023 $392 · 2024 $710 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $374 |
| Inspire Medical Systems, Inc. | 2 | $170 |
| GlaxoSmithKline, LLC. | 11 | $150 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| Corcept Therapeutics | 3 | $74 |
| SANOFI-AVENTIS U.S. LLC | 2 | $52 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Boston Scientific Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
Products named: REPATHA, INSPIRE, TRELEGY ELLIPTA, LEQVIO, Korlym, TZIELD, REXULTI, GEMTESA.
Industry payments across AZ — which companies pay providers there.
